OrbiMed Capital GP VI LLC, Director at Ikena Oncology, Inc. (IKNA), bought 252,225 shares at $3.55 ($1.1M) on 2022-06-22, disclosed to the SEC on 2022-06-24.
Scheduled purchase ($1.1M) by Director.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.55 | 66,806 | $237K | 21.0% |
| 2 | $3.71 | 23,419 | $87K | 7.7% |
| 3 | $4.37 | 65,965 | $288K | 25.6% |
| 4 | $5.37 | 96,035 | $516K | 45.7% |
| Total | $4.47 avg | 252,225 | $1.1M | 100% |
| Filing → |
| IRON | SELL | 2025-03-12 | $32.4M | — | Filing → |
| SCPH | BUY | 2024-08-15 | $2.0M | — | Filing → |
| NPCE | SELL | 2024-04-18 | $435K | — | Filing → |